1. Home
  2. LVS vs ONC Comparison

LVS vs ONC Comparison

Compare LVS & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

N/A

Current Price

$53.38

Market Cap

36.0B

ML Signal

N/A

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$298.97

Market Cap

33.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LVS
ONC
Founded
1988
2010
Country
United States
Switzerland
Employees
N/A
11000
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0B
33.1B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
LVS
ONC
Price
$53.38
$298.97
Analyst Decision
Buy
Strong Buy
Analyst Count
13
10
Target Price
$69.46
$386.70
AVG Volume (30 Days)
4.0M
237.2K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
2.24%
N/A
EPS Growth
19.90
N/A
EPS
2.35
N/A
Revenue
$13,017,000,000.00
N/A
Revenue This Year
$7.08
$770.07
Revenue Next Year
$4.47
$15.48
P/E Ratio
$22.95
$614.06
Revenue Growth
15.22
N/A
52 Week Low
$30.18
$196.53
52 Week High
$70.45
$385.22

Technical Indicators

Market Signals
Indicator
LVS
ONC
Relative Strength Index (RSI) 35.36 34.24
Support Level $53.63 $292.79
Resistance Level $55.49 $316.78
Average True Range (ATR) 1.65 9.97
MACD -0.11 -6.28
Stochastic Oscillator 23.54 13.58

Price Performance

Historical Comparison
LVS
ONC

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: